Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Clinical trial NCT04906460 · RECRUITING

Trial details

NCT number: NCT04906460
Sponsor: Wave Life Sciences USA, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy

Start date: 2021-09-28
Primary completion: 2026-06-27
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.